sec filing
IR
NASDAQ · IRON
Disc Medicine, Inc.
Healthcare · Biotechnology
$66.44
Down-$1.20 (-1.81%)
Updated Sep 26, 2026, 12:29 AM
SID Score
3.5/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.53B
- P/E ratio
- -18.17
- Dividend yield
- 0.00%
- 52-week range
- $40.00 – $99.50
- Volume
- 455.57K
- Avg. volume
- 503.23K
Price performance
IRON price history
1M range · 19 trading sessions · Daily adjusted prices
IRON closed at $66.44 after 19 trading sessions, down 16.98% for the selected period.
- Last close
- $66.44
- Period change
- -16.98%
- Period low
- $66.09
- Period high
- $80.05
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $66.09 | $66.58 | $64.31 | $66.44 | 455.57K |
| Sep 23, 2026 | $68.54 | $68.945 | $65.31 | $66.09 | 541.83K |
| Sep 22, 2026 | $69.65 | $69.79 | $67.68 | $68.48 | 450.84K |
| Sep 21, 2026 | $69.84 | $69.84 | $67.155 | $68.49 | 406.55K |
| Sep 18, 2026 | $69.13 | $69.60 | $67.705 | $69.53 | 1.08M |
| Sep 17, 2026 | $69.84 | $72.07 | $68.47 | $69.18 | 621.69K |
| Sep 16, 2026 | $67.88 | $70.00 | $67.49 | $68.57 | 433.92K |
| Sep 15, 2026 | $68.86 | $69.445 | $66.72 | $67.30 | 603.9K |
| Sep 14, 2026 | $70.06 | $70.8309 | $67.52 | $68.92 | 694.98K |
| Sep 11, 2026 | $74.66 | $75.00 | $69.275 | $70.06 | 628.95K |
| Sep 10, 2026 | $75.89 | $76.59 | $73.16 | $74.14 | 480.87K |
| Sep 9, 2026 | $76.55 | $77.265 | $75.24 | $76.51 | 719.51K |
| Sep 8, 2026 | $76.71 | $79.13 | $74.50 | $76.84 | 463.34K |
| Sep 4, 2026 | $78.14 | $80.01 | $78.14 | $79.23 | 204.86K |
| Sep 3, 2026 | $80.34 | $80.885 | $78.275 | $79.37 | 503.91K |
| Sep 2, 2026 | $79.44 | $81.01 | $77.6804 | $80.05 | 522.55K |
| Sep 1, 2026 | $78.56 | $79.95 | $75.88 | $78.67 | 549.44K |
| Aug 31, 2026 | $79.19 | $80.525 | $77.50 | $78.65 | 882.04K |
| Aug 28, 2026 | $81.79 | $82.70 | $79.77 | $80.03 | 665.58K |
Latest IRON news
The latest Smart Investors Daily articles mentioning IRON.
Stock researchResearch & News · SEC Filings
Loading stock research…